SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-003169
Filing Date
2023-05-11
Accepted
2023-05-11 08:30:43
Documents
20
Period of Report
2023-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 47608
2 CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PR pharmacyte_ex0301.htm EX-3.1 347368
3 WARRANT pharmacyte_ex0401.htm EX-4.1 180274
4 SECURITIES PURCHASE AGREEMENT pharmacyte_ex1001.htm EX-10.1 321889
5 REGISTRATION RIGHTS AGREEMENT pharmacyte_ex1002.htm EX-10.2 170876
6 AGREEMENT pharmacyte_ex1003.htm EX-10.3 86809
7 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 18412
11 GRAPHIC image_001.jpg GRAPHIC 5192
12 GRAPHIC image_002.jpg GRAPHIC 246855
  Complete submission text file 0001683168-23-003169.txt   1978289

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE pmcb-20230509.xsd EX-101.SCH 3291
9 XBRL LABEL FILE pmcb-20230509_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE pmcb-20230509_pre.xml EX-101.PRE 22363
14 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3711
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 23909007
SIC: 2836 Biological Products, (No Diagnostic Substances)